Clinical-stage Israeli biopharmaceutical company developing enteral therapies for premature neonates. Lead product: NTR-01, an IGF-1 analog delivered enterally to promote GI tract maturation and prevent complications of prematurity.
Contact company
Register for free to see this company’s contact details and get in touch.
We only use technical cookies that are necessary for the site to work and to keep you signed in. We do not use analytics or advertising cookies.
Cookies